Recombinant multi-species SLP76/LCP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLP76/LCP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an adapter protein that acts as a substrate of the T cell antigen receptor (TCR)-activated protein tyrosine kinase pathway. The encoded protein associates with growth factor receptor bound protein 2, and is thought to play a role TCR-mediated intracellular signal transduction. A similar protein in mouse plays a role in normal T-cell development and activation. Mice lacking this gene show subcutaneous and intraperitoneal fetal hemorrhaging, dysfunctional platelets and impaired viability. [provided by RefSeq, Nov 2016]
The Alternative Names of target: IMD81,LCP2,Lcp2,Lymphocyte cytosolic protein 2,SH2 domain-containing leukocyte protein of 76 kDa,SLP-76,SLP-76 tyrosine phosphoprotein (SLP76),SLP76,Slp76,m1Khoe,twm

Target products collectionGo to SLP76/LCP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP8657-Ag-1/ GM-Tg-hg-IP8657-Ag-2 Human SLP76/LCP2 protein Human
GM-Tg-rg-IP8657-Ag-1/ GM-Tg-rg-IP8657-Ag-2 Rat SLP76/LCP2 protein Rat
GM-Tg-mg-IP8657-Ag-1/ GM-Tg-mg-IP8657-Ag-2 Mouse SLP76/LCP2 protein Mouse
GM-Tg-cynog-IP8657-Ag-1/ GM-Tg-cynog-IP8657-Ag-2 Cynomolgus/Rhesus macaque SLP76/LCP2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP8657-Ag-1/ GM-Tg-felg-IP8657-Ag-2 Feline SLP76/LCP2 protein Feline
GM-Tg-cang-IP8657-Ag-1/ GM-Tg-cang-IP8657-Ag-2 Canine SLP76/LCP2 protein Canine
GM-Tg-bovg-IP8657-Ag-1/ GM-Tg-bovg-IP8657-Ag-2 Bovine SLP76/LCP2 protein Bovine
GM-Tg-equg-IP8657-Ag-1/ GM-Tg-equg-IP8657-Ag-2 Equine SLP76/LCP2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP8657-Ag-1/ GM-Tg-hg-IP8657-Ag-2; GM-Tg-rg-IP8657-Ag-1/ GM-Tg-rg-IP8657-Ag-2;
GM-Tg-mg-IP8657-Ag-1/ GM-Tg-mg-IP8657-Ag-2; GM-Tg-cynog-IP8657-Ag-1/ GM-Tg-cynog-IP8657-Ag-2;
GM-Tg-felg-IP8657-Ag-1/ GM-Tg-felg-IP8657-Ag-2; GM-Tg-cang-IP8657-Ag-1/ GM-Tg-cang-IP8657-Ag-2;
GM-Tg-bovg-IP8657-Ag-1/ GM-Tg-bovg-IP8657-Ag-2; GM-Tg-equg-IP8657-Ag-1/ GM-Tg-equg-IP8657-Ag-2
Products Name SLP76/LCP2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SLP76/LCP2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLP76/LCP2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.